Published in Neurology on February 01, 1994
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A (1994) 2.70
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol Med (1996) 1.68
The myth of maternal transmission of spongiform encephalopathy. BMJ (1995) 1.63
Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (1998) 1.43
Etiology and pathogenesis of prion diseases. Am J Pathol (1995) 1.35
Is Creutzfeldt-Jakob disease transmitted in blood? Emerg Infect Dis (1997) 1.19
Conformational pH dependence of intermediate states during oligomerization of the human prion protein. Protein Sci (2008) 0.88
Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro. Protein Sci (2005) 0.83
PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin Auton Res (2008) 0.82
Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry (1994) 0.81
Codon 219 polymorphism of PRNP in healthy Caucasians and Creutzfeldt-Jakob disease patients. Am J Hum Genet (1996) 0.81
Prions, beta-sheets and transmissible dementias: is there still something missing? Acta Neuropathol (1995) 0.78
Infectious amyloid precursor gene sequences in primates used for experimental transmission of human spongiform encephalopathy. Proc Natl Acad Sci U S A (1994) 0.78
Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study. Br J Med Med Res (2014) 0.75
Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. J Neurol Neurosurg Psychiatry (1996) 0.75
Creutzfeldt-Jakob disease in health professionals in Slovakia. Eur J Epidemiol (2000) 0.75
Genotype frequencies at codon 129 of the prion protein gene in Brazil: Implications in susceptibility to variant Creutzfeldt-Jakob disease compared to European and Asian populations. Eur J Epidemiol (2005) 0.75
Ancestral origins of the prion protein gene D178N mutation in the Basque Country. Hum Genet (2005) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20
Development of broad-host-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome. J Bacteriol (1982) 5.05
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet (2004) 4.85
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet (1992) 3.74
Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet (1999) 3.39
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 3.03
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Creutzfeldt-Jakob disease and blood transfusion. Lancet (1993) 2.97
Real and imagined clinicopathological limits of "prion dementia". Lancet (1993) 2.96
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (2000) 2.92
Differential methylation of genes and retrotransposons facilitates shotgun sequencing of the maize genome. Nat Genet (1999) 2.87
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry (1984) 2.68
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis (2001) 2.62
Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59
Gene trap tagging of PROLIFERA, an essential MCM2-3-5-like gene in Arabidopsis. Science (1995) 2.57
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion (2000) 2.52
Toluene degradation by Pseudomonas putida F1: genetic organization of the tod operon. Appl Environ Microbiol (1988) 2.44
zA map for sequence analysis of the Arabidopsis thaliana genome. Nat Genet (1999) 2.39
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry (2010) 2.29
Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet (1998) 2.17
The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet (1991) 2.16
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1982) 2.15
Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature (1992) 2.11
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med (2000) 2.04
Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle (2011) 2.01
Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet (2001) 1.97
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol (1986) 1.95
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology (1996) 1.87
Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84
In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol (1984) 1.80
The Arabidopsis SKP1-LIKE1 gene is essential for male meiosis and may control homologue separation. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang (2006) 1.76
Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol (1985) 1.75
Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc Natl Acad Sci U S A (1986) 1.75
Identification of cis-diols as intermediates in the oxidation of aromatic acids by a strain of Pseudomonas putida that contains a TOL plasmid. J Bacteriol (1986) 1.75
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
Amount of research interest in rare and common neurological conditions: bibliometric study. BMJ (2001) 1.68
Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J Gen Virol (1986) 1.67
An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity. J Biol Chem (1991) 1.64
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60
Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet (1994) 1.59
Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet (1991) 1.56
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology (1993) 1.55
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med (2001) 1.53
A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49
Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol (1991) 1.48
Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am J Hum Genet (1999) 1.46
Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet (1990) 1.44
Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (1998) 1.43
Variant CJD and blood transfusion: are there additional cases? Vox Sang (2014) 1.42
Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet (1999) 1.42
Congo red prolongs the incubation period in scrapie-infected hamsters. J Virol (1995) 1.42
Risk factors for variant Creutzfeldt-Jakob disease in dental practice: a case-control study. Br Dent J (2012) 1.42
Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol (1992) 1.42
Creutzfeldt-Jakob disease in Europe. Lancet (1995) 1.41
Codon 129 genotype and new variant CJD. Lancet (1997) 1.40
Vaccines and variant CJD. Vaccine (2000) 1.40
Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J Gen Virol (1987) 1.39
Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease. J Gen Virol (1985) 1.38
Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann Neurol (1998) 1.37